AU Patent

AU2008283357B2 — Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof

Assigned to Shionogi and Co Ltd · Expires 2011-08-11 · 15y expired

What this patent protects

Disclosed is an optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity. Also disclosed is a pharmaceutical composition containing such a compound as an active ingredient, which makes an orally administrable platelet production control agent…

USPTO Abstract

Disclosed is an optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity. Also disclosed is a pharmaceutical composition containing such a compound as an active ingredient, which makes an orally administrable platelet production control agent. Specifically disclosed is a pharmaceutical composition containing, as an active ingredient, an optically active compound represented by the formula below, a pharmaceutically acceptable salt thereof, or a solvate of any of them. (In the formula, R represents a halogen atom or a C-C alkyloxy group; R represents a C-C alkyl group; R represents a C-C alkyl group; R and R independently represent a fluorine atom or a chlorine atom; R represents a C-C alkyl group or a C-C alkyloxy group; and * represents an asymmetric carbon atom.)

Drugs covered by this patent

Patent Metadata

Patent number
AU2008283357B2
Jurisdiction
AU
Classification
Expires
2011-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.